WUXI BIOLOGICS CAYMAN INC USD00000083 144A REG S WXIBF
COM · Common Stock · CUSIP G97008117
1
institutional holders
+0 vs Q4 2020
9.2m
shares reported held*
$115.7mreported value*
0 new
1 added
0 reduced
0 sold out
net bought ≈ $1.4m (+107.9k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $12.52.
Trends to Q1 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2020 | 1 |
| Q1 2021 | 1 |
Biggest buyers
| GILDER GAGNON HOWE & CO LLC | Added | +107.9k |
Biggest sellers
| None |
Holders, Q1 2021
| Manager | Shares | Change |
|---|---|---|
| GILDER GAGNON HOWE & CO LLC 0.62% of their portfolio | 9.2m $115.7m | Added +107.9k |